Dr Jana Lynn Fahmy, MD | |
1304 Fawcett Ave Ste 100, Tacoma, WA 98402 | |
(253) 761-4200 | |
(253) 761-4201 |
Full Name | Dr Jana Lynn Fahmy |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 37 Years |
Location | 1304 Fawcett Ave Ste 100, Tacoma, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003989179 | NPI | - | NPPES |
0139020 | Other | WA | LNI TRA-MINW, PS KING COUNTY |
1090576 | Medicaid | WA | |
0139021 | Other | WA | LNI UAOM |
7252FA | Other | WA | REGENCE BLUE SHIELD UNION AVENUE OPEN |
0139020 | Other | WA | LNI TRA-MINW, PS REST OF WA |
3231FA | Other | WA | REGENCE BLUE SHIELD TRA |
8254112 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085U0001X | Radiology - Diagnostic Ultrasound | 00038576 (Washington) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | MD00038576 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
Multicare Good Samaritan Hospital | Puyallup, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tra-minw P S | 2163316167 | 123 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Entity Name | Radia Inc P S |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932196607 PECOS PAC ID: 9931012812 Enrollment ID: O20031106000749 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Entity Name | Tra-minw P S |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396814166 PECOS PAC ID: 2163316167 Enrollment ID: O20040211000326 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Entity Name | Union Avenue Open Mri Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568531242 PECOS PAC ID: 5597652917 Enrollment ID: O20040301001189 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Entity Name | Medical Imaging Northwest - Good Samaritan Hospital Imaging Alliance |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083802946 PECOS PAC ID: 3375603970 Enrollment ID: O20081126000315 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jana Lynn Fahmy, MD Po Box 1535, Tacoma, WA 98401-1535 Ph: (253) 761-4200 | Dr Jana Lynn Fahmy, MD 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Ph: (253) 761-4200 |
News Archive
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
› Verified 1 days ago
Dr. Yuyao Zhang, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Phone: 253-761-4201 Fax: 253-761-4201 | |
Mark Ranier Dalisay, Radiology Medicare: Not Enrolled in Medicare Practice Location: 7520 S I St, Tacoma, WA 98408 Phone: 702-305-1889 | |
Dr. Joel Thomas Mcfarland, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 Fax: 253-596-3301 | |
Dr. Scott Randall Henneman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1304 Fawcett Ave Ste 100, Tacoma, WA 98402 Phone: 253-761-4200 Fax: 253-761-4201 | |
Dr. Mark Gerard O'callaghan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Peter Alan Ory, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1304 Fawcett Ave, Suite 100, Tacoma, WA 98402 Phone: 253-680-3372 Fax: 253-383-3553 |